Related Experiment Video
Updated: May 16, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
[Associations of glycated albumin level with coronary artery disease]
Ya-ping Hao1, Xiao-jing Ma, Mi Zhou
1Department of Endocrinology & Metabolism, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai 200233, China.
Insights
Elevated glycated albumin (GA) levels are significantly higher in patients with coronary artery disease (CAD). This finding indicates that GA is an independent risk factor for CAD, even in individuals with normal glucose tolerance.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Glycemic control is crucial in managing cardiovascular health.
- Glycated albumin (GA) is a marker of short-term glycemic control.
Purpose of the Study:
- To investigate the association between serum glycated albumin (GA) levels and the presence of coronary artery disease (CAD).
- To determine if GA is an independent risk factor for CAD.
Main Methods:
- A cohort of 306 patients undergoing coronary angiography (CA) was analyzed.
- Patients were categorized based on the presence or absence of CAD.
- Logistic regression analysis was employed to assess independent correlations.
Main Results:
- Coronary artery disease (CAD) was diagnosed in 74.2% of the study population.
- Patients with CAD exhibited significantly higher levels of 2-hour postprandial glucose, GA, and hemoglobin A1c compared to non-CAD patients.
- Elevated GA levels were independently associated with CAD in both normal glucose tolerance (NGR) and hyperglycemia subgroups.
Conclusions:
- Serum GA levels are significantly elevated in patients with CAD.
- Glycated albumin (GA) serves as an independent risk factor for coronary artery disease (CAD) across different glucose tolerance statuses.
Objective:
To explore the associations of the level of glycated albumin (GA) with coronary artery disease (CAD).
Methods:
A total of 306 patients undergoing coronary angiography (CA) were collected. There were 201 males and 105 females with an age range of 38-86 years. CA was the major diagnostic criteria of CAD. Metabolic syndrome was diagnosed according to the Guideline on Prevention & Treatment of Blood Lipid Abnormality in Chinese Adults.
Results:
(1) CAD was found in 227 patients (74.2%). The levels of 2 h postprandial glucose, GA and hemoglobin A1c in the CAD patients were higher than those in the non-CAD counterparts (all P < 0.05). (2) In the subgroup of normal glucose tolerance (NGR), the CAD patients had a higher level of GA than the non-CAD patients ((15.0 ± 2.1)% vs (13.3 ± 1.7)%, P < 0.01). And the level of GA was higher in the patients with 1-vessel ((14.8 ± 2.1)% vs (13.3 ± 1.7)%, P < 0.05) and multi-vessel lesions ((15.1 ± 2.1)% vs (13.3 ± 1.7)%, P < 0.05) than that in the non-CAD counterparts (all P < 0.05). Similar results were obtained in the hyperglycemia subgroup. (3) Logistic regression demonstrated that the level of GA was independently correlated with CAD after adjusting other traditional factors among all subjects, NGR and hyperglycemia subgroup.
Conclusions:
The serum level of GA becomes significantly elevated the CAD patients. And it is an independent risk factor of CAD in both hyperglycemic and NGR patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Diabetic Nephropathy
Acute Coronary Syndrome III: Diagnostic Studies